Guardant Health Inc
NASDAQ:GH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Guardant Health Inc
NASDAQ:GH
|
US |
|
Ansal Properties and Infrastructure Ltd
NSE:ANSALAPI
|
IN |
|
P
|
Pan Asia Footwear PCL
SET:PAF
|
TH |
Intrinsic Value
The intrinsic value of Guardant Health Inc (GH) under the Base Case is 42.32 USD per share.
Compared with the current market price of 158 USD, the stock appears
Overvalued by 73% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Guardant Health Does
Guardant Health makes blood-based tests for cancer. Its main products are liquid biopsy tests that look for tumor DNA in a patient’s blood, helping doctors detect cancer, choose treatment, and watch for signs that disease may be returning. The company sells these tests to oncologists, hospitals, health systems, and patients through the medical care process.
- Headquarters
- United States of America US
- Employees
- 2 498
- IPO date
- Oct 4, 2018
Revenue & Expenses Breakdown
Guardant Health Inc
Earnings Waterfall
Guardant Health Inc
The intrinsic value for Guardant Health Inc (GH) under the Base Case is 42.32 USD.
Compared with the current market price of 158 USD, the stock appears Overvalued by 73% .